Safety and Efficacy of Drug Combinations Against Trichuris Trichiura

• Status: Completed
• Trial end date: 2009-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: DBL -Institute for Health Research and Development
• Treatments: Albendazole; DMP 777; Ivermectin; Mebendazole; Piperazine; Piperazine citrate

Criteria

Inclusion Criteria:

• Those who are enrolled in class one to six

• Are infected with T. trichiura

• Whose parent consent and who are willing to participate

Exclusion Criteria:

• Those with acute and chronic diseases other than T. trichiura

• Those with a history of any serious adverse drug reactions